Objectives of the visit
The visit had several key objectives, including:
- Understanding Uttarakhand’s approach to cannabis regulation: Uttarakhand has been at the forefront of progressive cannabis policies in India. To know more about the policy checkout this article. The committee sought to gain insights into the state’s framework and its impact on the local economy and society.
- Exploring collaborative opportunities: The visit aimed to foster collaboration between Himachal Pradesh and Uttarakhand, enabling knowledge-sharing and joint research and development initiatives in the field of cannabis.
The Future of Cannabis in India
Before delving into the details of the Himachal Hemp Policy Committee’s visit, it is crucial to understand the current legal status of cannabis in India and the potential benefits of its legalization.
Current legal status of cannabis in India
Cannabis, popularly known as marijuana or ganja, is classified as a Schedule I substance under the Narcotic Drugs and Psychotropic Substances (NDPS) Act of 1985 in India. This classification implies that cannabis is considered a highly controlled substance with strict regulations and penalties for its possession, cultivation, and distribution.
However, recent global trends and research highlighting the potential medical, economic, and industrial applications of cannabis have led to a reevaluation of its legal status in various countries, including India.
Potential benefits of legalizing cannabis
The potential benefits of legalizing cannabis are multifaceted. From a medicinal perspective, cannabis has shown promise in alleviating symptoms associated with various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and cancer-related side effects. Legalization would allow patients access to regulated, quality-controlled cannabis-based medications.
Furthermore, the economic potential of cannabis cannot be ignored. Hemp, a non-intoxicating variety of cannabis, has a wide range of applications in industries such as textiles, construction, and biofuel. Legalizing hemp cultivation and processing could create employment opportunities and contribute to sustainable economic growth.
Himachal Hemp Policy Committee’s Visit to Uttarakhand
Uttarakhand’s progressive approach to cannabis
Uttarakhand has emerged as a pioneer in India’s cannabis regulation landscape. The state government recognizes the economic and medicinal potential of cannabis and has implemented policies to support its cultivation and utilization. Uttarakhand permits the cultivation of hemp for industrial purposes and has established a framework for licensing and regulation.
Highlights of the committee’s visit
During their visit, the Himachal Hemp Policy Committee engaged in discussions with policymakers, researchers, and industry representatives in Uttarakhand. The highlights of their visit included:
- Field visits to hemp cultivation sites: The committee had the opportunity to observe hemp cultivation practices in Uttarakhand, gaining insights into sustainable farming techniques, crop management, and the economic viability of hemp cultivation.
- Knowledge-sharing sessions: Experts from Uttarakhand shared their experiences, research findings, and success stories related to cannabis cultivation, processing, and commercialization. These sessions facilitated an exchange of ideas and best practices.
- Collaborative efforts for research and development: The visit paved the way for collaborative research and development initiatives between Himachal Pradesh and Uttarakhand. Joint projects focusing on optimizing cannabis varieties, developing novel applications, and addressing regulatory challenges were discussed.
Exploring the National Control Bureau (NCB) Headquarters
NCB’s role in regulating narcotics and illicit substances
The National Control Bureau (NCB) is the nodal agency in India responsible for combating the production, trafficking, and abuse of narcotics and illicit substances. It plays a crucial role in enforcing the NDPS Act and coordinating efforts at the national level.
Discussions and insights from the visit
The Himachal Hemp Policy Committee’s visit to the NCB Headquarters provided a valuable opportunity to engage with officials and gain insights into the regulatory framework surrounding cannabis. Discussions focused on understanding the challenges faced by the NCB in combating illegal cannabis activities, the importance of robust regulations, and the potential impact of policy changes.
Challenges and Opportunities in Cannabis Regulation
While the future of cannabis regulation in India looks promising, it is not without its challenges. Addressing concerns related to abuse, addiction, and diversion of cannabis for illicit purposes is of paramount importance. Striking a balance between access for medical purposes and preventing misuse requires a comprehensive regulatory framework and public awareness campaigns.
Despite the challenges, the opportunities that arise from cannabis regulation are significant. It opens doors for scientific research, medical advancements, economic growth, and sustainable development. With careful planning and evidence-based.
The committee also discussed about the GI tagging of the cannabis species plant grown in Himachal Pradesh.
The committee also meet various industrial leaders in hemp sector, From Bombay Hemp Company (BOHECO) Mr.Delzaad Deolaliwala , addresses the meeting. Mr.Srijan Sharma from Its Hemp , Mr. Siddharth Gupta and Mr.Harsh Sachdev from Indian Hempstore , Mr.Akhilesh Singh from Bhangola , Mr. J.P Maithani from Aagas Federation . Mr. Gaurav Dixit & Mrs. Namrata Kandwal from Gohemp Agro Ventures , they also showcased Hemp Creet industrial material which can replace existing cement made concrete structure to a sustainable alternative, Ms.Aseel Ali from Hemplify with Department of Excise & Customs & other industrial leaders.
Formation of HP Hemp Policy Committee is indeed a step in the right direction.
It may be recalled that the Delhi based Institute for Narcotics Studies and Analysis (INSA), had conducted a study on the subject and in its report published in 2016 on drug problems of HP (http://narcoinsa.in/resource/Research/image/2016_Insa%20Report_Kullu-Conference.pdf)
had, inter alia recommended that the State should take an evidence based decision to use cannabis for industrial and medicinal use. Relevant excerpts from the report are given below:
” v) Since cannabis is scientifically known to be a very good source of high quality fibre and biomass for a number of industrial uses and the NDPS Act read with the National Policy on Narcotics Drugs and Psychotropic Substances provides for cultivation of cannabis for medicinal and scientific purposes, the Government of India and the State Government should immediately make use of these enabling legal provisions and allow research based industrial use of cannabis varieties having low tetrahydrocannabinol (THC), albeit with adequate safeguards against possible misuse thereof.
(vi) A number of countries have already moved ahead in this field and India should not continue to lag behind in harnessing its natural resources.”
That’s why INSA sees formation of this Committee as a step in the right direction, which it hopes will lead to the right decision in near future.
It may not be out of place to mention that a number of states in America have already allowed medicinal use of cannabis in their respective jurisdictions and President Joe Biden is reported to have asked the US Secretary Health and the Attorney General to review classification of cannabis as a schedule-1 drug.
We hope the Government of India too shall make a review of its current policy on cannabis.